Zerrin Atakan

6.6k total citations · 2 hit papers
59 papers, 4.3k citations indexed

About

Zerrin Atakan is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Zerrin Atakan has authored 59 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 22 papers in Psychiatry and Mental health and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Zerrin Atakan's work include Cannabis and Cannabinoid Research (33 papers), Schizophrenia research and treatment (18 papers) and Neuroscience and Neuropharmacology Research (12 papers). Zerrin Atakan is often cited by papers focused on Cannabis and Cannabinoid Research (33 papers), Schizophrenia research and treatment (18 papers) and Neuroscience and Neuropharmacology Research (12 papers). Zerrin Atakan collaborates with scholars based in United Kingdom, Brazil and Australia. Zerrin Atakan's co-authors include Philip McGuire, Rocı́o Martı́n-Santos, Sagnik Bhattacharyya, Paolo Fusar‐Poli, Antônio Waldo Zuardi, José Alexandre S. Crippa, Stefan Borgwardt, Paul Allen, Marc L. Seal and Robin Murray and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Zerrin Atakan

59 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

2009 541 citations Sagnik Bhattacharyya, Paul D. Morrison et al. Neuropsychopharmacology profile →
Cannabis, a complex plant: different compounds and different effects on individuals

2012 390 citations Zerrin Atakan Therapeutic Advances in Psychopharmacology profile →

Peers

Countries citing papers authored by Zerrin Atakan

Since Specialization

Citations

This map shows the geographic impact of Zerrin Atakan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zerrin Atakan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zerrin Atakan more than expected).

Fields of papers citing papers by Zerrin Atakan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zerrin Atakan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zerrin Atakan. The network helps show where Zerrin Atakan may publish in the future.

Co-authorship network of co-authors of Zerrin Atakan

This figure shows the co-authorship network connecting the top 25 collaborators of Zerrin Atakan. A scholar is included among the top collaborators of Zerrin Atakan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zerrin Atakan. Zerrin Atakan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary intake, physical activity and sedentary behaviour patterns in a sample with established psychosis and associations with mental health symptomatology 2021 ·Psychological Medicine ·Rebecca Martland, Scott Teasdale, Robin Murray, Poonam Gardner-Sood, Shubuladè Smith, Khalida Ismail, Zerrin Atakan, Kathryn Greenwood, Brendon Stubbs, Fiona Gaughran	22
2	Predictive value of cardiometabolic biomarkers and depressive symptoms for symptom severity and quality of life in patients with psychotic disorders 2021 ·Journal of Affective Disorders ·(unknown), Simone Ciufolini, Poonam Gardner-Sood, Amir Krivoy, Allan H. Young, Robin Murray, Khalida Ismail, Zerrin Atakan, Kathryn Greenwood, Shubuladè Smith, Fiona Gaughran, Mário F. Juruena	1
3	A health promotion intervention to improve lifestyle choices and health outcomes in people with psychosis: a research programme including the IMPaCT RCT 2020 ·SHILAP Revista de lepidopterología ·Fiona Gaughran, Daniel Ståhl, Anita Patel, Khalida Ismail, Shubuladè Smith, Kathryn Greenwood, Zerrin Atakan, Poonam Gardner-Sood, Dominic Stringer, David Hopkins, John Lally, Marta Di Forti, Brendon Stubbs, Philippa Lowe, Maurice Arbuthnott, Margaret Heslin, Anthony S. David, Robin Murray	6
4	Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study 2019 ·The British Journal of Psychiatry ·Fiona Gaughran, Daniel Ståhl, Dominic Stringer, David Hopkins, Zerrin Atakan, Kathryn Greenwood, Anita Patel, Shubuladè Smith, Poonam Gardner-Sood, John Lally, Margaret Heslin, Brendon Stubbs, Stefania Bonaccorso, Anna Kolliakou, Oliver Howes, David Taylor, Marta Di Forti, Anthony S. David, Robin Murray, Khalida Ismail, (unknown)	21
5	Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects ofδ-9-THC 2018 ·Psychological Medicine ·Sagnik Bhattacharyya, (unknown), Paul Allen, Chiara Nosarti, Zerrin Atakan, Vincent Giampietro, Michael J. Brammer, Philip McGuire	10
6	Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT) 2017 ·BMC Psychiatry ·(unknown), Fiona Gaughran, Daniel Ståhl, Khalida Ismail, Kathryn Greenwood, Zerrin Atakan, Poonam Gardner-Sood, Brendon Stubbs, David Hopkins, Anita Patel, John Lally, Philippa Lowe, (unknown), (unknown), Sarah Corlett, Jonas Eberhard, Anthony S. David, Robin Murray, Shubuladè Smith	33
7	Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 2017 ·Schizophrenia Research ·John Lally, Olesya Ajnakina, Brendon Stubbs, (unknown), Marco Colizzi, Elena Carra, Sara Fraietta, Poonam Gardner-Sood, Kathryn Greenwood, Zerrin Atakan, Valeria Mondelli, Khalida Ismail, Oliver Howes, David Taylor, Shubuladè Smith, David Hopkins, Robin Murray, Fiona Gaughran	31
8	Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis 2014 ·European Neuropsychopharmacology ·Sagnik Bhattacharyya, Zerrin Atakan, Rocı́o Martı́n-Santos, José Alexandre S. Crippa, Joseph Kambeitz, (unknown), Vincent Giampietro, Steven Williams, M. Brammer, Katya Rubia, David Collier, Philip McGuire	60
9	Provision of health promotion programmes to people with serious mental illness: a mapping exercise of four South London boroughs 2013 ·Journal of Psychiatric and Mental Health Nursing ·(unknown), Poonam Gardner-Sood, (unknown), Khalida Ismail, Shubuladè Smith, Zerrin Atakan, Kathryn Greenwood, Corey Joseph, Fiona Gaughran	14
10	Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers 2012 ·Current Pharmaceutical Design ·Rocı́o Martı́n-Santos, José Alexandre S. Crippa, Albert Batalla, Sagnik Bhattacharyya, Zerrin Atakan, Stefan Borgwardt, Paul Allen, Marc L. Seal, Klaus Langohr, Magı́ Farré, (unknown), Philip McGuire	205
11	Cannabis, a complex plant: different compounds and different effects on individuals breakdown → 2012 ·Therapeutic Advances in Psychopharmacology ·Zerrin Atakan	390
12	Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies 2012 ·Current Pharmaceutical Design ·Sagnik Bhattacharyya, Zerrin Atakan, Rocı́o Martı́n-Santos, José Alexandre S. Crippa, Philip McGuire	54
13	The Effect of Cannabis on Perception of Time: A Critical Review 2012 ·Current Pharmaceutical Design ·Zerrin Atakan, Paul Morrison, Matthijs G. Bossong, Rocı́o Martı́n-Santos, José Alexandre S. Crippa	22
14	Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ⁹-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers 2012 ·Psychological Medicine ·Zerrin Atakan, Sagnik Bhattacharyya, Paul Allen, Rocı́o Martı́n-Santos, José Alexandre S. Crippa, Stefan Borgwardt, Paolo Fusar‐Poli, Marc L. Seal, Hannah Sallis, Daniel Ståhl, Antônio Waldo Zuardi, Katya Rubia, Philip McGuire	44
15	Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study 2011 ·Neuropsychopharmacology ·Toby Winton‐Brown, Paul Allen, (unknown), Stefan Borgwardt, Paolo Fusar‐Poli, José Alexandre S. Crippa, Marc L. Seal, Rocı́o Martı́n-Santos, Dominic ffytche, Antônio Waldo Zuardi, Zerrin Atakan, Philip McGuire	111
16	Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report 2010 ·Journal of Psychopharmacology ·José Alexandre S. Crippa, (unknown), (unknown), Lauro Wichert‐Ana, (unknown), Rocı́o Martı́n-Santos, Marcus Vinı́cius Simões, Sagnik Bhattacharyya, Paolo Fusar‐Poli, Zerrin Atakan, Alaor Santos Filho, (unknown), Philip McGuire, Antônio Waldo Zuardi, Geraldo F. Busatto, Jaime E. C. Hallak	392
17	Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol 2009 ·The International Journal of Neuropsychopharmacology ·Paolo Fusar‐Poli, Paul Allen, Sagnik Bhattacharyya, José Alexandre S. Crippa, Andrea Mechelli, Stefan Borgwardt, Rocı́o Martı́n-Santos, Marc L. Seal, (unknown), Zerrin Atakan, Antônio Waldo Zuardi, Philip McGuire	136
18	Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology breakdown → 2009 ·Neuropsychopharmacology ·Sagnik Bhattacharyya, Paul D. Morrison, Paolo Fusar‐Poli, Rocı́o Martı́n-Santos, Stefan Borgwardt, Toby Winton‐Brown, Chiara Nosarti, (unknown), Marc L. Seal, Paul Allen, Mitul A. Mehta, James Stone, Nigel Tunstall, Vincent Giampietro, Shitij Kapur, Robin Murray, Antônio Waldo Zuardi, José Alexandre S. Crippa, Zerrin Atakan, Philip McGuire	541
19	The Prediction of Violence in Acute Psychiatric Units 2003 ·International Journal of Forensic Mental Health ·David Watts, Morven Leese, Stuart Thomas, Zerrin Atakan, Til Wykes	9
20	ABC of mental health: Mental health emergencies 1997 ·BMJ ·Zerrin Atakan, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact